Radiology Registry on Pancreatic Malignancies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥18 years of age
Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage.
able and willing to sign informed consent
Disqualifiers
Patients with non-primary pancreatic disease
Trial population
Patients with pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, rare forms of pancreatic cancer (such as ampullary cancer, adenosquamous carcinomas, squamous cell carcinomas, signet ring cell carcinomas, undifferentiated carcinomas, and undifferentiated carcinomas with giant cells) and cystic neoplasms.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Radiology evaluations and interventions
Other interventionDiagnostic and interventional radiology procedures
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Progression- free survival
Time from start of observation to disease progression
Time frame
From date of intervention until the date of first documented progression, up to a maximum of 3 years2
Local progression free survival
Time between (start of) a locoregional treatment and local disease progression
Time frame
From date of intervention until the date of first documented local progression assessed up to a maximum of 3 yearsSecondary outcomes
1
Overall Survival
The length of time from either the date of diagnosis or the start of treatment for a disease, in which the patients are still alive
Time frame
From date of treatment until the date of death from any cause assessed up to 3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov